AKER stock forecast
Our latest prediction for Akers Biosciences, Inc.'s stock price was made on the Feb. 28, 2020 when the stock price was at 2.78$.
In the short term (2weeks), AKER's stock price should outperform the market by 1.53%. During that period the price should oscillate between -14.57% and +20.65%.
In the medium term (3months), AKER's stock price should underperform the market by -3.07%. During that period the price should oscillate between -48.26% and +58.27%.Get email alerts
About Akers Biosciences, Inc.
Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -12.96$ per share.
The book value per share is 0.11$
Three months stock forecastFeb. 28, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|